Bionic GTM, powered by BoardFluent.
Bionic GTM™ runs your go-to-market on the numbers your board already reads.
BoardFluent is the GTM operating system that scores your go-to-market on the same versioned formulas your board already reads, then tracks whether the fixes moved the number. The GTM Execution dashboards are built for operating teams to run themselves. Bionic GTM is the operator practice that runs them for you and signs the result.
The rubric, the formulas, the evidence standards, and the outcome tracking live in the platform. The operator brings judgment and stands behind the result. The platform keeps both anchored to the numbers the board sees.
On the platform
We run the sequence and sign the result.
Diagnose, quantify, operate, and prove are dashboards built into BoardFluent, real product functionality any team could run on its own. Bionic GTM runs them for clients who would rather hand the sequence to an operator: intake, scoring, the quantified plan, the operating cadence, and the proof that it moved the number, all inside the client's own BoardFluent account.
Beyond the platform
Operator work the dashboards do not cover.
Fractional and interim revenue leadership for companies between CROs. GTM diligence for investors evaluating or holding a software company. Custom engagements scoped to a specific board or transaction question.
Every engagement runs on BoardFluent, the GTM operating system that scores the go-to-market on the same versioned formulas the board reads.
Visit boardfluent.com
The operator
Senior operator judgment, anchored to the platform.
Bionic GTM engagements are guided by Mike Dayton, founder of BoardFluent and an experienced GTM operator who has led revenue as CRO, CSO, and GM across PE-backed, public, and founder-led software companies. He assists and advises through every engagement, and the platform keeps each score, plan, and re-score anchored to the numbers the board sees.
About Bionic GTMStart with a scored read on where the gap is.
Qualified companies get a free GTM Diagnostic: a scored, evidence-based read on the go-to-market, requested through a short form.